EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study

Daniel R Quast iD, Cong Xie, Michelle J Bound, Jacqueline Grivell, Seva Hatzinikolas, Karen L Jones iD, Michael Horowitz, Christopher K Rayner iD, Michael A Nauck iD, Juris J Meier, Liza K Phillips, Tongzhi Wu iD

Diabetes · 01.04.2025 · 74 (4) · 611-618

DOI: 10.2337/db24-0830 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, online erschienen am 06.01.2025. Verfasst von Daniel R Quast und 11 weiteren Autor:innen. Beteiligte Einrichtung: Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, Austra…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin, Gastric Emptying, Blood Pressure. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Hospital Research Foundation, University of Adelaide, Royal Adelaide Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with type 2 diabetes are at high risk of postprandial decrease in blood pressure (BP; i.e., a reduction in systolic BP of ≥20 mmHg, termed postprandial hypotension [PPH]), which increases the risk of falls and mortality. This study evaluated the effects of oral metformin on postprandial BP, heart rate (HR), glucagon-like peptide 1 (GLP-1), and gastric emptying (GE) in individuals with type 2 diabetes. We studied 16 patients (five women) before and after ingestion of a 75-g radiolabeled glucose drink, after both acute (30 min) and subacute (twice per day for 7 days) administration of metformin (850 mg) or placebo, according to a double-blind randomized crossover design. To quantify PPH events, 24-h ambulatory BP measurement after standardized meals (breakfast, lunch, and dinner) was used. The primary outcome was postprandial decrease in systolic BP. We found that acute administration of metformin did not affect BP, HR, plasma insulin, or GLP-1 levels but slowed GE (P < 0.001) and reduced glycemic response to oral glucose (P < 0.001). Subacute metformin increased HR (P = 0.029), slowed GE (P < 0.001), augmented plasma GLP-1 (P < 0.001) and reduced plasma glucose (P < 0.001) in response to oral glucose, without affecting plasma insulin. Moreover, subacute metformin reduced postprandial falls in systolic BP (P = 0.0002) and PPH events (P = 0.035) during ambulatory BP measurement. Preprandial BP was unaffected by metformin. To conclude, in type 2 diabetes, oral metformin attenuates the hypotensive response to meals, in association with stimulation of GLP-1 and slowing of GE, to reduce PPH. Article Highlights Postprandial hypotension (PPH) occurs frequently in type 2 diabetes. Metformin has cardiovascular effects independent of its glucose-lowering capacity, which may modulate the risk of PPH. We investigated the effects of metformin on postprandial blood pressure, including PPH events, heart rate, glucose, insulin, glucagon-like peptide 1 (GLP-1), and gastric emptying, in individuals with type 2 diabetes. Metformin attenuated postprandial decrease in blood pressure and reduced PPH events, in association with augmentation of plasma GLP-1, slowed gastric emptying, and increased heart rate, in type 2 diabetes. These findings establish novel cardiovascular effects of metformin that may mitigate the risk of PPH in type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MetforminGastric EmptyingBlood PressureGlucagon-Like Peptide 1Heart RateHypotensionHypoglycemic AgentsHumansMaleDouble-Blind MethodPostprandial PeriodMiddle AgedFemaleCross-Over StudiesAgedBlood GlucosePrevalence

Substanzen

MetforminGlucagon-Like Peptide 1Hypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, Australia.
  • Diabetes, Endocrinology and Metabolism Section, Department of Internal Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Department of Internal Medicine, Augusta-Hospital, Bochum, Germany.

ORCID-Profile: Daniel R Quast, Karen L Jones, Christopher K Rayner, Michael A Nauck, Tongzhi Wu

Förderung

  • Hospital Research Foundation
  • University of Adelaide
  • Royal Adelaide Hospital
  • Royal Adelaide Hospital Research Fund

Zitieren

APA

Quast, D. R., Xie, C., Bound, M. J., Grivell, J., Hatzinikolas, S., Jones, K. L., Horowitz, M., Rayner, C. K., Nauck, M. A., Meier, J. J., Phillips, L. K., & Wu, T. (2025). Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study. Diabetes, 74(4), 611-618. https://doi.org/10.2337/db24-0830

Vancouver

Quast DR, Xie C, Bound MJ, Grivell J, Hatzinikolas S, Jones KL, et al. Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study. Diabetes. 2025;74(4):611-618. doi:10.2337/db24-0830

BibTeX
@article{Quast2025,
  author = {Quast, Daniel R and Xie, Cong and Bound, Michelle J and Grivell, Jacqueline and Hatzinikolas, Seva and Jones, Karen L and Horowitz, Michael and Rayner, Christopher K and Nauck, Michael A and Meier, Juris J and Phillips, Liza K and Wu, Tongzhi},
  title = {Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study},
  journal = {Diabetes},
  year = {2025},
  volume = {74},
  number = {4},
  pages = {611--618},
  doi = {10.2337/db24-0830}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche